Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustavo Pacheco-Rodriguez

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Critical Reviews in Immunology|July 30, 2010
The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cellsGustavo Pacheco-Rodriguez, Joel Moss
Methods in Enzymology|January 18, 2006
Cytohesin-1: structure, function, and ARF activationGustavo Pacheco-Rodriguez, Joel Moss, Martha Vaughan
Methods in Enzymology|October 23, 2001
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factorsGustavo Pacheco-Rodriguez, Joel Moss, Martha Vaughan
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2002
ARF-directed guanine-nucleotide-exchange (GEP) proteinsGustavo Pacheco-Rodriguez, Joel Moss, Martha Vaughan
Lymphatic Research and Biology|December 27, 2011
Pulmonary lymphangiomatosisMelissa N Satria, Gustavo Pacheco-Rodriguez, Joel Moss
Lymphatic Research and Biology|March 19, 2010
The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosisAngelo M Taveira-DaSilva, Gustavo Pacheco-Rodriguez, Joel Moss
Clinics in Chest Medicine|August 13, 2016
Benign Metastasizing LeiomyomaGustavo Pacheco-Rodriguez, Angelo M Taveira-DaSilva, Joel Moss
JCI Insight|March 8, 2019
Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosisWendy K Steagall, Mario Stylianou, Gustavo Pacheco-Rodriguez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2005
LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanismsArnold S Kristof, Gustavo Pacheco-Rodriguez, Bruno Schremmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2004
Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factorsPhilip Ian Padilla, Gustavo Pacheco-Rodriguez, Joel Moss, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Critical Reviews in Immunology|July 30, 2010
The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cellsGustavo Pacheco-Rodriguez, Joel Moss
Methods in Enzymology|January 18, 2006
Cytohesin-1: structure, function, and ARF activationGustavo Pacheco-Rodriguez, Joel Moss, Martha Vaughan
Methods in Enzymology|October 23, 2001
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factorsGustavo Pacheco-Rodriguez, Joel Moss, Martha Vaughan
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2002
ARF-directed guanine-nucleotide-exchange (GEP) proteinsGustavo Pacheco-Rodriguez, Joel Moss, Martha Vaughan
Lymphatic Research and Biology|December 27, 2011
Pulmonary lymphangiomatosisMelissa N Satria, Gustavo Pacheco-Rodriguez, Joel Moss
Lymphatic Research and Biology|March 19, 2010
The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosisAngelo M Taveira-DaSilva, Gustavo Pacheco-Rodriguez, Joel Moss
Clinics in Chest Medicine|August 13, 2016
Benign Metastasizing LeiomyomaGustavo Pacheco-Rodriguez, Angelo M Taveira-DaSilva, Joel Moss
JCI Insight|March 8, 2019
Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosisWendy K Steagall, Mario Stylianou, Gustavo Pacheco-Rodriguez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2005
LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanismsArnold S Kristof, Gustavo Pacheco-Rodriguez, Bruno Schremmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2004
Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factorsPhilip Ian Padilla, Gustavo Pacheco-Rodriguez, Joel Moss, et al.
Pageof 6